References
- Benard Y., Lemenager J., Morel C. A comparative study of amoxycillin and ‘Augmentin’ in the treatment of bronchopulmonary infections. “Augmentin–Clavulanate-potentiated Amoxycillin. Proceedings of the European Symposium”, E. A. P. Croyden, M. F. Michel. Scheven-ingen, The Netherlands 1983; 278–281, June Curr. Clin. Pract. Ser. No. 4. Excerpta Medica, Amsterdam1. Benard Y., Lemenager J., Morel C. A comparative study of amoxycillin and ‘Augmentin’ in the treatment of bronchopulmonary infections. “Augmentin–Clavulanate-potentiated Amoxycillin. Proceedings of the European Symposium”, E. A. P. Croyden, M. F. Michel. Scheven-ingen, The Netherlands 1983; 278–281, June Curr. Clin. Pract. Ser. No. 4. Excerpta Medica, Amsterdam
- Brogden R. N., Carmine A., Heel R. C., Morley P. A., Speight T. M., Avery G. S. Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use. Drugs 1981; 22: 357, 3622. Brogden R. N., Carmine A., Heel R. C., Morley P. A., Speight T. M., Avery G. S. Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use. Drugs 1981; 22: 357, 362
- Maddocks J. L., May J. R. Indirect pathogenicity of penicillinase-producing enterobacteria in chronic bronchial infections. Lancet 1969; 1: 7933. Maddocks J. L., May J. R. Indirect pathogenicity of penicillinase-producing enterobacteria in chronic bronchial infections. Lancet 1969; 1: 793
- Miki R, Takamatsu K., Kohno M. Comparison of BRL 25000 (clavulanic acid-amoxycillin) and amoxycillin in the treatment of chronic respiratory tract infections. Chemotherapy (Tokyo) 1983; 31: 1–43, Suppl. 24. Miki R, Takamatsu K., Kohno M. Comparison of BRL 25000 (clavulanic acid-amoxycillin) and amoxycillin in the treatment of chronic respiratory tract infections. Chemotherapy (Tokyo) 1983; 31: 1–43, Suppl. 2
- Slocombe B., Beale A. S., Boon R. J., Griffin K. E., Masters P. J., Sutherland R., White A. R. Antibacterial activity in vitro and in vivo of amoxycillin in the presence of clavulanic acid. “Progress and Perspectives on Beta-lactamase Inhibition: A Review of Augmentin”. Postgrad. Med. Custom Communications, New York 1984; 29–495. Slocombe B., Beale A. S., Boon R. J., Griffin K. E., Masters P. J., Sutherland R., White A. R. Antibacterial activity in vitro and in vivo of amoxycillin in the presence of clavulanic acid. “Progress and Perspectives on Beta-lactamase Inhibition: A Review of Augmentin”. Postgrad. Med. Custom Communications, New York 1984; 29–49